Reaction

Gestational Hypertension reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,262 reports · 19 co-occurring drugs

As of the last recalculation, Gestational Hypertension appears in 1,262 FAERS reports alongside 19 co-occurring drug terms. The strongest observed disproportionality signal is LABETALOL (PRR 41.9).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Labetalol3341.942.0
Rimegepant Sulfate2127.827.8
Dimenhydrinate1523.523.5
Butalbital, Acetaminophen, And Caffeine1320.320.3
Pegvaliase-Pqpz816.216.2
Fluticasone Furoate1013.713.7
Nicotine Polacrilex Mini1112.212.2
Nicotine Polarilex1112.212.2
Peginterferon Beta-1A911.411.4
Brexpiprazole1111.011.0
Progesterone1510.910.9
Anakinra1010.010.0
Sumatriptan Succinate159.99.9
Atazanavir89.29.2
Lurasidone Hydrochloride118.78.7
Oseltamivir48.38.3
Elexacaftor, Tezacaftor, And Ivacaftor45.35.3
Onabotulinumtoxina214.54.5
Copper31.11.1

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.